Christoph Renner

Person

Zurich, CH

People

Patents Grantslast 30 patents

Information Patent Grant
MHC class Ia open conformers
- Patent number 11,807,676
- Issue date Nov 7, 2023
- Universitat Zurich
- Osiris Marroquin Belaunzaran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of HLA-B27 homodimers for cancer treatment
- Patent number 11,484,572
- Issue date Nov 1, 2022
- Universitat Basel
- Osiris Marroquin Belaunzaran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating cancer with an HLA-B57 open conformer
- Patent number 11,369,660
- Issue date Jun 28, 2022
- Universitat Zurich
- Osiris Marroquin Belaunzaran
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MHC class Ia fusion dimers for treatment of cancer
- Patent number 11,279,747
- Issue date Mar 22, 2022
- Universitat Zurich
- Osiris Marroquin Belaunzaran
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-fibroblast activation protein antibodies and methods and uses...
- Patent number 8,999,342
- Issue date Apr 7, 2015
- Ludwig Institute for Cancer Research, Ltd.
- Christoph Renner
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING HLA FUSION PROTEINS
- Publication number 20240366718
- Publication date Nov 7, 2024
- IMMUNOS THERAPEUTICS AG
- Osiris MARROQUIN BELAUNZARAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A MODIFIED HLA-B57 WITH INCREASED EXPRESSION LEVELS
- Publication number 20240269232
- Publication date Aug 15, 2024
- IMMUNOS THERAPEUTICS AG
- Osiris MARROQUIN BELAUNZARAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HLA-B57 OPEN CONFORMERS
- Publication number 20220339250
- Publication date Oct 27, 2022
- Universitat Zurich
- Osiris MARROQUIN BELAUNZARAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MHC CLASS IA OPEN CONFORMERS
- Publication number 20220185865
- Publication date Jun 16, 2022
- Universitat Zurich
- Osiris MARROQUIN BELAUNZARAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HLA-B57 OPEN CONFORMERS
- Publication number 20190247466
- Publication date Aug 15, 2019
- Universitat Zurich
- Osiris MARROQUIN BELAUNZARAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MHC CLASS IA OPEN CONFORMERS
- Publication number 20190169263
- Publication date Jun 6, 2019
- Universitat Zurich
- Osiris MARROQUIN BELAUNZARAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF HLA-B27 HOMODIMERS FOR CANCER TREATMENT
- Publication number 20180028606
- Publication date Feb 1, 2018
- Universitat Zurich
- Osiris MARROQUIN BELAUNZARAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed Against HLA-B27 Homodimers and Methods and Uses...
- Publication number 20130315933
- Publication date Nov 28, 2013
- Christoph Renner
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-FIBROBLAST ACTIVATION PROTEIN ANTIBODIES AND METHODS AND USES...
- Publication number 20120258119
- Publication date Oct 11, 2012
- Christoph Renner
- C07 - ORGANIC CHEMISTRY

Christoph Renner

Person

Patents Grantslast 30 patents

MHC class Ia open conformers

Use of HLA-B27 homodimers for cancer treatment

Method of treating cancer with an HLA-B57 open conformer

MHC class Ia fusion dimers for treatment of cancer

Anti-fibroblast activation protein antibodies and methods and uses...

Patents Applicationslast 30 patents

PHARMACEUTICAL COMPOSITIONS COMPRISING HLA FUSION PROTEINS

A MODIFIED HLA-B57 WITH INCREASED EXPRESSION LEVELS

HLA-B57 OPEN CONFORMERS

MHC CLASS IA OPEN CONFORMERS

HLA-B57 OPEN CONFORMERS

MHC CLASS IA OPEN CONFORMERS

USE OF HLA-B27 HOMODIMERS FOR CANCER TREATMENT

Antibodies Directed Against HLA-B27 Homodimers and Methods and Uses...

ANTI-FIBROBLAST ACTIVATION PROTEIN ANTIBODIES AND METHODS AND USES...